Table 2 Study variables through four follow-up examinations in males and females.
Male | Female | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Follow-up examination 1 | Follow-up examination 2 | Follow-up examination 3 | Follow-up examination 4 | Trend | Follow-up examination 1 | Follow-up examination 2 | Follow-up examination 3 | Follow-up examination 4 | Trend | |||
β | P-value | β | P-value | |||||||||
Age (Year) | 18.14 ± 2.37 | 21.76 ± 2.48 | 25.06 ± 2.46 | 28.08 ± 2.42 | 3.27 | < 0.001 | 18.33 ± 2.24 | 21.71 ± 2.34 | 25.03 ± 2.49 | 28.08 ± 2.46 | 3.23 | < 0.001 |
Smoking (%) | 118 (17.4) | 158 (23.3) | 185 (27.4) | 207 (30.7) | – | – | 46 (6.3) | 32 (4.4) | 38 (5.2) | 50 (6.8) | – | – |
BMI (kg/m2) | 23.54 ± 4.9 | 24.72 ± 5.05 | 24.96 ± 4.88 | 25.78 ± 5.27 | 0.97 | < 0.001 | 22.43 ± 4.08 | 23.36 ± 4.3 | 23.72 ± 4.43 | 23.96 ± 4.53 | 0.61 | < 0.001 |
SBP (mmHg) | 108.46 ± 11.38 | 111.20 ± 12.07 | 110.79 ± 11.85 | 111.2 ± 11.32 | 1.38 | < 0.001 | 99.10 ± 10.82 | 100.30 ± 10.73 | 101.04 ± 11.31 | 99.99 ± 10.31 | 0.10 | 0.45 |
DBP (mmHg) | 70.37 ± 8.89 | 73.26 ± 9.07 | 73.58 ± 8.50 | 75.13 ± 8.38 | 1.81 | < 0.001 | 66.34 ± 8.81 | 67.81 ± 8.89 | 68.09 ± 8.68 | 68.14 ± 8.10 | 0.02 | 0.83 |
LTPA (MET-hour/week) | 21.21 ± 23.75 | 18.31 ± 20.76 | 17.21 ± 18.15 | 16.12 ± 16.10 | -2.77 | < 0.001 | 11.05 ± 15.82 | 9.36 ± 11.19 | 8.53 ± 10.10 | 8.19 ± 10.27 | -1.43 | < 0.001 |
Insufficient LTPA (%) | 445 (65.6) | 407 (60.0) | 371 (54.7) | 389 (57.4) | – | – | 612 (83.4) | 570 (77.7) | 586 (79.8) | 576 (78.5) | – | – |